Diligent Pharma, Inc. is a private vendor management qualification organization, offering a centralized technology platform for streamlining vendor qualification in clinical trial execution. Diligent is transforming the current approach to identifying and qualifying clinical trial vendors and is driving innovation while mitigating risks and addressing the need for speed and high quality in the process.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 05/15/23 | $8,270,000 | Series A |
FCA Venture Partners GenHenn Capital PJC | undisclosed |
